Benzinga | Jul 28, 2021 04:19PM EDT

Exact Sciences Q2 EPS $(1.03) Misses $(0.76) Estimate, Sales $434.80M Beat $421.28M Estimate

Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(1.03) per share which missed the analyst consensus estimate of $(0.76) by 35.53 percent. This is a 77.59 percent decrease over losses of $(0.58) per share from the same period last year. The company reported quarterly sales of $434.80 million which beat the analyst consensus estimate of $421.28 million by 3.21 percent. This is a 61.72 percent increase over sales of $268.87 million the same period last year.